Published in Kidney Int on June 01, 2005
Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden. Adv Chronic Kidney Dis (2008) 1.98
Prevalence and correlates of cognitive impairment in hemodialysis patients: the Frequent Hemodialysis Network trials. Clin J Am Soc Nephrol (2010) 1.55
Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies. Kidney Int (2010) 1.47
Prevalence and significance of stroke symptoms among patients receiving maintenance dialysis. Neurology (2012) 1.47
Neurological complications of chronic kidney disease. Nat Rev Neurol (2009) 0.93
Silent Brain Infarction and Risk of Future Stroke: A Systematic Review and Meta-Analysis. Stroke (2016) 0.87
Factors affecting cerebral oxygenation in hemodialysis patients: cerebral oxygenation associates with pH, hemodialysis duration, serum albumin concentration, and diabetes mellitus. PLoS One (2015) 0.81
Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients. Am J Nephrol (2016) 0.75
Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice. J Immunol (2008) 2.45
Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas. Clin Cancer Res (2011) 2.23
The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice. J Immunol (2005) 2.16
Poor glycemic control is a major factor in the overestimation of glomerular filtration rate in diabetic patients. Diabetes Care (2013) 2.15
Expression of peroxisome proliferator-activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists. Int J Cancer (2003) 1.86
B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis. Am J Pathol (2006) 1.64
Overview of regular dialysis treatment in Japan (as of 31 December 2008). Ther Apher Dial (2010) 1.62
Cerebral microbleeds in predialysis patients with chronic kidney disease. Nephrol Dial Transplant (2009) 1.58
2005 Japanese Society for Dialysis Therapy guidelines for vascular access construction and repair for chronic hemodialysis. Ther Apher Dial (2006) 1.54
Involvement of estrogen receptors in prostatic diseases. Int J Urol (2012) 1.49
Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanism. Transplantation (2002) 1.45
Prolonging survival in metastatic renal cell carcinoma patients treated with targeted anticancer agents: a single-center experience of treatment strategy modifications. Can J Urol (2015) 1.40
Efficacy of naftopidil for nocturia in male patients with lower urinary tract symptoms: comparison of morning and evening dosing. Int J Urol (2014) 1.39
An overview of regular dialysis treatment in Japan (as of 31 December 2010). Ther Apher Dial (2012) 1.37
Primary hyperparathyroidism with multiple osteosclerotic lesions of the calvarium. J Bone Miner Res (2003) 1.35
Overview of regular dialysis treatment in Japan (as of 31 December 2011). Ther Apher Dial (2013) 1.29
Effects of liposome clodronate on renal leukocyte populations and renal fibrosis in murine obstructive nephropathy. J Pharmacol Sci (2009) 1.27
Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis (2003) 1.25
Quantitative identification of mutant alleles derived from lung cancer in plasma cell-free DNA via anomaly detection using deep sequencing data. PLoS One (2013) 1.19
A novel steroid receptor co-activator protein (SRAP) as an alternative form of steroid receptor RNA-activator gene: expression in prostate cancer cells and enhancement of androgen receptor activity. Biochem J (2003) 1.15
Overview of regular dialysis treatment in Japan as of 31 December 2006. Ther Apher Dial (2008) 1.14
Silent cerebral infarction in hemodialysis patients. Am J Nephrol (2002) 1.13
Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer. Prostate (2002) 1.13
Overview of regular dialysis treatment in Japan (as of 31 December 2009). Ther Apher Dial (2012) 1.11
An overview of regular dialysis treatment in Japan (as of 31 December 2012). Ther Apher Dial (2014) 1.11
The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol (2002) 1.10
A case of renal cell carcinoma found after skin metastasis. Hinyokika Kiyo (2004) 1.08
Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors. Int J Oncol (2004) 1.07
Telmisartan is a potent target for prevention and treatment in human prostate cancer. Oncol Rep (2008) 1.07
Inhibition of NEDD8-conjugation pathway by novel molecules: potential approaches to anticancer therapy. Mol Oncol (2012) 1.05
Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts. J Gastroenterol (2011) 1.02
Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma. J Gastroenterol (2007) 1.01
Rapid detoxification of cereulide in Bacillus cereus food poisoning. Pediatrics (2010) 0.99
Carcinoid tumor of the kidney presenting as a large abdominal mass: report of a case. Surg Today (2004) 0.99
Differential contribution of three mitogen-activated protein kinases to PDGF-BB-induced mesangial cell proliferation and gene expression. J Am Soc Nephrol (2003) 0.98
Renal allograft arteriovenous fistula and large pseudoaneurysm. Clin Transplant (2003) 0.98
Synergistic antitumor effect of S-1 and HER2-targeting agents in gastric cancer with HER2 amplification. Mol Cancer Ther (2010) 0.98
Attenuation of renal fibrosis by proteasome inhibition in rat obstructive nephropathy: possible role of nuclear factor kappaB. Int J Mol Med (2003) 0.98
An overview of regular dialysis treatment in Japan (as of 31 December 2007). Ther Apher Dial (2009) 0.98
Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis. Oncol Rep (2007) 0.97
Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase. Mol Cancer Ther (2008) 0.97
Attenuation of renal fibrosis by curcumin in rat obstructive nephropathy. Urology (2006) 0.97
Clinical experience with autofluorescence imaging system in patients with lung cancers and precancerous lesions. Respiration (2006) 0.96
Regulatory failure of serum prohepcidin levels in patients with hepatitis C. Hepatol Res (2006) 0.96
Severely impaired B lymphocyte proliferation, survival, and induction of the c-Myc:Cullin 1 ubiquitin ligase pathway resulting from CD22 deficiency on the C57BL/6 genetic background. J Immunol (2004) 0.96
Role of the heme regulatory motif in the heme-mediated inhibition of mitochondrial import of 5-aminolevulinate synthase. J Biochem (2004) 0.95
Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists. Urology (2002) 0.94
Oral fluoropyrimidine S-1 combined with leucovorin is a promising therapy for colorectal cancer: Evidence from a xenograft model of folate-depleted mice. Mol Med Rep (2011) 0.93
Addition of S-1 to the epidermal growth factor receptor inhibitor gefitinib overcomes gefitinib resistance in non-small cell lung cancer cell lines with MET amplification. Clin Cancer Res (2009) 0.93
Spheroid culture of primary lung cancer cells with neuregulin 1/HER3 pathway activation. J Thorac Oncol (2013) 0.93
The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells. Int J Mol Med (2003) 0.92
Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors. J Urol (2003) 0.92
Dissection of B cell differentiation during primary immune responses in mice with altered CD40 signals. Int Immunol (2002) 0.91
5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway. Oncol Rep (2005) 0.91
IL-17 production by γδ T cells is important for the antitumor effect of Mycobacterium bovis bacillus Calmette-Guérin treatment against bladder cancer. Eur J Immunol (2010) 0.91
Bacteriological water quality in the central dialysis fluid delivery system from the survey of the Japanese Society for Dialysis Therapy. Blood Purif (2009) 0.90
Tumor-forming idiopathic retroperitoneal fibrosis: report of a case. Surg Today (2004) 0.90
Chondrosarcoma of the urinary bladder and establishment of a human chondrosarcoma cell line (OCUU-6). Hum Cell (2004) 0.90
Diagnostic localization of extra-adrenal pheochromocytoma: comparison of (123)I-MIBG imaging and (131)I-MIBG imaging. Oncol Rep (2002) 0.89
Increased antitumor activity in combined treatment TS-1 and docetaxel. A preclinical study using gastric cancer xenografts. Oncology (2005) 0.89
A study of innate immunity in patients with end-stage renal disease: special reference to toll-like receptor-2 and -4 expression in peripheral blood monocytes of hemodialysis patients. Int J Mol Med (2007) 0.88
The effects of cyclooxygenase-2 inhibitors on urological cancer cells. Int J Mol Med (2004) 0.88
[Primary mucosa-associated lymphoid tissue (MALT) lymphoma of the urinary bladder]. Hinyokika Kiyo (2005) 0.88
Ureterocolic fistula detected on bone scintigraphy. Indian J Gastroenterol (2004) 0.88
Overview of regular dialysis treatment in Japan (as of 31 December 2005). Ther Apher Dial (2007) 0.88
Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus. Am J Kidney Dis (2002) 0.88
Metastatic urinary bladder tumor from extragonadal germ cell tumor: a case report. Oncol Rep (2002) 0.88
Determination of ABO blood grouping from human oral squamous epithelium by the highly sensitive immunohistochemical staining method EnVision+. J Forensic Sci (2002) 0.88
Molecular mechanisms and therapeutic strategies of chronic renal injury: the role of nuclear factor kappaB activation in the development of renal fibrosis. J Pharmacol Sci (2006) 0.88
Clinical outcome of ABO-incompatible living unrelated donor kidney transplantation. Urol Int (2011) 0.88
Role for thromboxane A2 from glomerular thrombi in nephropathy with type 2 diabetic rats. Life Sci (2003) 0.88
Association of prostate cancer and manganese superoxide dismutase AA genotype influenced by presence of occult cancer in control group. Urology (2008) 0.87
Association of right-sided tumors with high thymidine phosphorylase gene expression levels and the response to oral uracil and tegafur/leucovorin chemotherapy among patients with colorectal cancer. Cancer Chemother Pharmacol (2012) 0.87
Overexpression of orotate phosphoribosyl transferase in hormone-refractory prostate cancer. Oncol Rep (2009) 0.87
Intrarenal hemodynamic changes after captopril test in patients with type 2 diabetes: a duplex Doppler sonography study. Diabetes Care (2003) 0.87
Inhibition of nuclear factor-kappaB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy. Kidney Int (2003) 0.87